Health Condition 1: J309- Allergic rhinitis, unspecified
Conditions
Interventions
Intervention1: Combination of Lactic acid bacillus, Nicotinamide, and Pyridoxine hydrochloride: Along with standard drugs probiotics will be administered orally once a day for 6 weeks
Control Interve
Sponsors
Arupadai Veedu Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 18 upto 50 years attending ENT OPD in AVMC presenting with symptoms of allergic rhinitis with blood investigations supporting the diagnosis of allergic rhinitis.
Exclusion criteria
Exclusion criteria: Patients with a history of severe allergic reactions or other significant comorbidities. Patients currently using probiotics or undergoing immunomodulatory therapy. Pregnant or lactating women. Patients previously diagnosed with GERD
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To asses Effectiveness of reducing symptoms and immunology marker levels .i.e. AEC count and Ige and diagnostic nasal endoscopy using probiotics as an adjunct with standard treatment for patients having Allergic Rhinitis.Timepoint: To asses Effectiveness of reducing symptoms and immunology marker levels at 2 weeks , 4 weeks ,6 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To establish the association of Laryngeal reflux/Gastro- oesophageal reflux with allergic rhinitis.Timepoint: at 2 weeks , 4 weeks ,6 weeks | — |
Countries
India
Contacts
Public ContactDr Sowmya Gajapathy
Aarupadai Veedu Medical College and Hospital
Outcome results
None listed